Glioblastoma (GBM) (Phase ll Only)-Enrollment Completed
1 clinical trials · Condition
◉ Watch Glioblastoma (GBM) (Phase ll Only)-Enrollment Completed
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (NCT02335918) | Celldex Therapeutics | 2015-01-01 |
Track Glioblastoma (GBM) (Phase ll Only)-Enrollment Completed automatically
Every clearance here is in the API, with alerts when new ones post.